Here’s why Aurumin (ASX: AUN) was up over 50% today!

Nick Sundich Nick Sundich, July 11, 2022

Aurumin (ASX: AUN) is one of the best performing ASX stocks today off the back of exploration results at its Central Sandstone Gold Project. The company is a gold explorer and mine developer and one of its recent purchases appears to be paying off.  

 

Aurumin (ASX:AUN) share price chart (Graph: TradingView)

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

Central Sandstone paying off for Aurumin  

Aurumin bought the Sandstone gold project from Middle Island Resources (ASX:MDI) for $12m. MDI reported positive exploration results at the project.  

Things all fell apart after a study last year found the economics did not stack up. But AUN amalgamated the project into its nearby Johnson Range project and it now appears more appealing – even before this morning’s results.  

It reported assay results of 344m @ 1.29g/t. This grade is only average (anything above 5g/t is typically high grade). But remember, this was a big intersection and it included some highlights with higher grades, including 16.1m @ 2.9g/t.  

 

What now for Aurumin? 

Aurumin will continue exploration at the project and build up its mineral resource. It has a Mineral Resource Estimate (MRE) of 14.2Mt @1.1g/t for 500,000koz at Two Mile Hill (an underground part of the project). The whole project has a combined resource of 849koz.  

We also think it could expand its footprint even further, having acquired its latest exploration license just three weeks ago. And with over 1Moz produced regionally at Sandstone in times gone by, shareholders are inevitably dreaming of eventual production.  

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

No credit card needed and the trial expires automatically.

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Nuix

Nuix (ASX:NXL) has quadrupled in 12 months! But is more growth to come?

Nuix (ASX:NXL) has been one of the most controversial companies on the ASX since it listed, but has it turned…

ASX Biotechs

Here are 3 ASX biotechs with major milestones coming right up!

Investing in ASX biotechs is a risky business, even more than most other companies on the market. Unless you own…

buy the dip

When do you know it’s time to ‘buy the dip’? You could be catching a falling knife

‘Buy the dip’ – have you ever heard that term? It implies that when a company’s share price ‘dips’ or decreases,…